COMMUNIQUÉS West-GlobeNewswire

IP veteran Andrew Filler joins BioSig Technologies’ Board of Directors

10/11/2017 - 14:00

Santa Monica, CA, Nov. 10, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]

VBI Vaccines to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at SITC 2017

10/11/2017 - 14:00

New data confirms use of intradermal delivery of eVLPs may be a potent “off-the-shelf” immunotherapy vaccine Poster presentation at the Society for Immunotherapy of Cancer’s (SITC) 32 nd Annual Meeting on Friday, [...]

India Globalization Capital Regains NYSE American Listing Compliance

10/11/2017 - 14:00

BETHESDA, Md., Nov. 10, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC) announced that it received a letter on November 9, 2017 from NYSE Regulation stating that it is in compliance with [...]

Beleave Supports Recent Council Decision and Continues Expansion Uninterrupted

10/11/2017 - 13:30

TORONTO, Nov. 10, 2017 (GLOBE NEWSWIRE) -- Beleave Inc. (“Beleave”) (CSE:BE) (OTCQX:BLEVF) strongly supports The City of Hamilton council’s decision to turn down the motion for any new restrictions pertaining to the [...]

HempTech (HTCO), a Nuvus Company, to Exhibit New Grow.Droid Line of Products, Artificial Intelligent (AI) grow systems and GrowComm App at Marijuana Business Conference & Expo in Vegas - Nov 15-17, Booth #2323

10/11/2017 - 13:23

Saint Petersburg, FL, Nov. 10, 2017 (GLOBE NEWSWIRE) -- HempTech Corp. (OTC PINK: HTCO), a provider of advanced Controlled Environment Agriculture (CEA) with sophisticated automation and analytical tools for the [...]

Myriad Collaborates with Department of Veterans Affairs in Large Trial Evaluating the GeneSight® Test to Improve Mental Health Outcomes for Veterans

10/11/2017 - 13:05

SALT LAKE CITY, Nov. 10, 2017 (GLOBE NEWSWIRE) -- Assurex Health, a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ: MYGN ), today announced that the Department of Veterans Affairs (VA) recently initiated a [...]

ContraFect to Present at the 2nd Annual Superdrugs and Superbugs USA Conference

10/11/2017 - 13:00

YONKERS, N.Y., Nov. 10, 2017 (GLOBE NEWSWIRE) -- ContraFect Corporation (NASDAQ: CFRX ), a biotechnology company focused on the discovery and development of protein and antibody therapeutics for life-threatening, drug- [...]

Deciphera Pharmaceuticals, Inc. Reports Data Analysis from the Ongoing Phase 1 Clinical Trial of DCC-2618 at the Annual Meeting of The Connective Tissue Oncology Society

10/11/2017 - 13:00

- Data Support the Selection of the Recommended Daily Dose of 150 mg - - Durable Disease Control Rates in Heavily Pretreated GIST Patients and Reductions in KIT Mutations Supporting pan-KIT Activity of DCC-2618 Across [...]

Onconova Therapeutics Announces Pricing of Public Offering of Common Stock

10/11/2017 - 13:00

NEWTOWN, Pa., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ), a Phase 3 stage biopharmaceutical company focused on discovering and developing small molecule drug candidates to treat cancer [...]

Zomedica Pharmaceuticals Corp. Announces NYSE American Listing Approval

10/11/2017 - 12:55

ANN ARBOR, Mich., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V: ZOM ) ("Zomedica" or the "Company"), a veterinary pharmaceutical and health care solutions company, today announced that the [...]

USPTO approves BioPorto’s NGAL Trauma patent for issuance

10/11/2017 - 11:50

United States Patent and Trademark Office (USPTO) has announced, that BioPorto's NGAL Trauma patent, specifically relating to diagnosing and treating radiation injury, has been approved for issuance. BioPortos’ issued [...]

Herantis Pharma's Manager's Transactions

10/11/2017 - 08:01

Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 10 Nov 2017 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the [...]

Herantis Pharma's Manager's Transactions

10/11/2017 - 08:01

Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 10 Nov 2017 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the [...]

Herantis Pharma's Manager's Transactions

10/11/2017 - 08:00

Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 10 Nov 2017 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the [...]

Herantis Pharma's Manager's Transactions

10/11/2017 - 08:00

Herantis Pharma's Manager's Transactions Herantis Pharma Plc Company release 10 Nov 2017 at 9:00 am Herantis Pharma Oyj - Managers' Transactions ____________________________________________ Person subject to the [...]

Nine-month interim report (Q3) 2017

10/11/2017 - 07:30

Copenhagen, 2017-11-10 07:30 CET (GLOBE NEWSWIRE) -- Performance for the period (unaudited) (Comparative figures for 2016 are shown in brackets. Revenue growth is measured in local currencies. 2016 comparative figures [...]

MediciNova Appoints Hideki Nagao to its Board of Directors

10/11/2017 - 07:30

LA JOLLA, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

10/11/2017 - 07:02

REGULATED INFORMATION GHENT, Belgium, 10 November 2017 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

Sarepta Therapeutics Announces Exercise of Initial Purchasers’ Option to Purchase Additional Convertible Senior Notes Due 2024

10/11/2017 - 03:45

CAMBRIDGE, Mass., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to [...]